Skip to main content
. 2022 Mar 31;5(3):e224506. doi: 10.1001/jamanetworkopen.2022.4506

Figure 3. Adjusted Analyses on the Comparison Between Intravenous Tenecteplase and Alteplase for the Outcomes of 3-Month Good Functional Outcome (Modified Rankin Scale 0-2), Successful Recanalization, Early Neurological Improvement, and 3-Month Excellent Functional Outcome (Modified Rankin Scale 0-1).

Figure 3.

The size of squares is proportional to the weight of each study. Horizontal lines indicate the 95% CI of each study; diamond, the pooled estimate with 95% CI.